Wound exudate proteases (WEP)

Wound exudate proteases refer to a group of proteolytic enzymes, primarily matrix metalloproteinases (MMPs) and serine proteases like neutrophil elastase, that are found in the fluid secreted by healing or chronic wounds. In a healthy healing environment, these enzymes play a critical role in debriding damaged tissue and remodeling the extracellular matrix (ECM) to facilitate cell migration and tissue regeneration (Source: PubMed, PMID: 17716247). However, in chronic wounds such as diabetic foot ulcers or venous leg ulcers, an imbalance occurs where elevated levels of these proteases lead to the excessive degradation of essential growth factors and ECM components, effectively stalling the healing process (Source: NIH, StatPearls). Therapeutic strategies targeting wound exudate proteases focus on restoring the biochemical balance within the wound bed. This is often achieved through the use of advanced wound dressings, such as those containing collagen or oxidized regenerated cellulose, which bind and inactivate excess proteases (Source: Journal of Wound Care). Additionally, pharmacological inhibitors like doxycycline have been explored for their ability to inhibit MMP activity. By reducing the proteolytic burden, these interventions aim to protect the wound's structural integrity and promote the transition from a chronic inflammatory state to an active proliferative phase of healing.

Other names

Chronic wound proteasesWound fluid proteasesMatrix metalloproteinases and serine proteasesProteolytic enzymes in wound fluid

Inhibition of proteolytic activity through competitive binding, sequestration of enzyme ions (like zinc), or physical adsorption to reduce the concentration of active enzymes in the wound bed.